O	O	0	11	Involvement	Involvement	B-NP	NN	O	0	ROOT	O
O	O	12	14	of	of	B-PP	IN	O	1	NMOD	O
T5	B-Entity	15	18	Alu	Alu	B-NP	NN	B-DNA	4	NMOD	B-DNA
T5	I-Entity	19	28	sequences	sequence	I-NP	NNS	I-DNA	2	PMOD	I-DNA
O	O	29	31	in	in	B-PP	IN	O	1	NMOD	O
O	O	32	35	the	the	B-NP	DT	O	10	NMOD	O
O	O	36	40	cell	cell	I-NP	NN	O	10	NMOD	O
O	O	40	41	-	-	B-NP	HYPH	O	10	NMOD	O
O	O	41	49	specific	specific	I-NP	JJ	O	10	NMOD	O
O	O	50	60	regulation	regulation	I-NP	NN	O	5	PMOD	O
O	O	61	63	of	of	B-PP	IN	O	10	NMOD	O
O	O	64	77	transcription	transcription	B-NP	NN	O	11	PMOD	O
O	O	78	80	of	of	B-PP	IN	O	12	NMOD	O
O	O	81	84	the	the	B-NP	DT	O	16	NMOD	O
O	O	85	90	gamma	gamma	I-NP	NN	B-protein	16	NMOD	B-protein
O	O	91	96	chain	chain	I-NP	NN	I-protein	13	PMOD	I-protein
O	O	97	99	of	of	B-PP	IN	O	16	NMOD	O
O	O	100	102	Fc	Fc	B-NP	NN	B-protein	22	NMOD	B-protein
O	O	103	106	and	and	O	CC	O	22	NMOD	O
O	O	107	108	T	T	B-NP	NN	B-protein	22	NMOD	B-protein
O	O	109	113	cell	cell	I-NP	NN	I-protein	22	NMOD	I-protein
O	O	114	123	receptors	receptor	I-NP	NNS	I-protein	17	PMOD	I-protein
O	O	123	124	.	.	O	.	O	1	P	O

O	O	126	129	The	The	B-NP	DT	O	4	NMOD	O
T1	B-Protein	130	132	Fc	Fc	I-NP	NN	B-protein	4	NMOD	B-protein
T1	I-Protein	133	140	epsilon	epsilon	I-NP	NN	I-protein	4	NMOD	I-protein
T1	I-Protein	141	143	RI	RI	I-NP	NN	I-protein	7	NMOD	I-protein
T1	I-Protein	143	144	-	-	O	HYPH	I-protein	7	NMOD	I-protein
T1	I-Protein	144	149	gamma	gamma	O	SYM	I-protein	7	NMOD	I-protein
T1	I-Protein	150	156	chains	chain	B-NP	NNS	I-protein	8	SUB	I-protein
O	O	157	160	are	be	B-VP	VBP	O	0	ROOT	O
O	O	161	170	expressed	express	I-VP	VBN	O	8	VC	O
O	O	171	173	in	in	B-PP	IN	O	9	VMOD	O
O	O	174	175	a	a	B-NP	DT	O	12	NMOD	O
O	O	176	183	variety	variety	I-NP	NN	O	10	PMOD	O
O	O	184	186	of	of	B-PP	IN	O	12	NMOD	O
O	O	187	200	hematopoietic	hematopoietic	B-NP	JJ	B-cell_type	15	NMOD	B-cell_type
O	O	201	206	cells	cell	I-NP	NNS	I-cell_type	13	PMOD	I-cell_type
O	O	207	212	where	where	B-ADVP	WRB	O	15	NMOD	O
O	O	213	217	they	they	B-NP	PRP	O	18	SUB	O
O	O	218	222	play	play	B-VP	VBP	O	16	SBAR	O
O	O	223	224	a	a	B-NP	DT	O	21	NMOD	O
O	O	225	233	critical	critical	I-NP	JJ	O	21	NMOD	O
O	O	234	238	role	role	I-NP	NN	O	18	OBJ	O
O	O	239	241	in	in	B-PP	IN	O	18	VMOD	O
O	O	242	248	signal	signal	B-NP	NN	O	24	NMOD	O
O	O	249	261	transduction	transduction	I-NP	NN	O	22	PMOD	O
O	O	261	262	.	.	O	.	O	8	P	O

O	O	263	267	They	They	B-NP	PRP	O	2	SUB	O
O	O	268	271	are	be	B-VP	VBP	O	0	ROOT	O
O	O	272	276	part	part	B-NP	NN	O	48	NMOD	O
O	O	277	279	of	of	B-PP	IN	O	3	NMOD	O
O	O	280	283	the	the	B-NP	DT	O	9	NMOD	O
T6	B-Entity	284	288	high	high	I-NP	JJ	B-protein	9	NMOD	B-protein
T6	I-Entity	289	297	affinity	affinity	I-NP	NN	I-protein	9	NMOD	I-protein
T6	I-Entity	298	301	IgE	IgE	I-NP	NN	I-protein	9	NMOD	I-protein
T6	I-Entity	302	310	receptor	receptor	I-NP	NN	I-protein	4	PMOD	I-protein
O	O	311	313	in	in	B-PP	IN	O	3	NMOD	O
O	O	314	318	mast	mast	B-NP	NN	B-cell_type	12	NMOD	B-cell_type
O	O	319	324	cells	cell	I-NP	NNS	I-cell_type	22	NMOD	I-cell_type
O	O	324	325	,	,	O	,	O	22	P	O
O	O	326	335	basophils	basophil	B-NP	NNS	B-cell_type	22	NMOD	B-cell_type
O	O	335	336	,	,	O	,	O	22	P	O
O	O	337	347	Langerhans	Langerhans	B-NP	NNP	B-cell_type	17	NMOD	B-cell_type
O	O	348	353	cells	cell	I-NP	NNS	I-cell_type	22	NMOD	I-cell_type
O	O	353	354	,	,	O	,	O	22	P	O
O	O	355	358	and	and	O	CC	O	22	NMOD	O
O	O	359	367	possibly	possibly	B-ADVP	RB	O	22	NMOD	O
O	O	368	373	other	other	B-NP	JJ	O	22	NMOD	O
O	O	374	379	cells	cell	I-NP	NNS	O	10	PMOD	O
O	O	379	380	;	;	O	:	O	48	P	O
O	O	381	382	a	a	B-NP	DT	O	25	NMOD	O
O	O	383	392	component	component	I-NP	NN	O	48	NMOD	O
O	O	393	395	of	of	B-PP	IN	O	25	NMOD	O
O	O	396	399	the	the	B-NP	DT	O	30	NMOD	O
T7	B-Entity	400	403	low	low	I-NP	JJ	O	30	NMOD	O
T7	I-Entity	404	412	affinity	affinity	I-NP	NN	O	30	NMOD	O
T7	I-Entity	413	421	receptor	receptor	I-NP	NN	O	26	PMOD	O
T7	I-Entity	422	425	for	for	B-PP	IN	O	30	NMOD	O
T7	I-Entity	426	429	IgG	IgG	B-NP	NN	B-protein	31	PMOD	B-protein
O	O	430	431	(	(	O	(	O	39	DEP	O
T2	B-Protein	431	433	Fc	Fc	B-NP	NN	B-protein	36	NMOD	B-protein
T2	I-Protein	434	439	gamma	gamma	I-NP	NN	I-protein	36	NMOD	I-protein
T2	I-Protein	440	445	RIIIA	RIIIA	I-NP	NN	I-protein	38	NMOD	I-protein
O	O	446	448	or	or	O	CC	O	38	NMOD	O
T3	B-Protein	449	453	CD16	CD16	B-NP	NN	B-protein	39	DEP	B-protein
O	O	453	454	)	)	O	)	O	32	NMOD	O
O	O	455	457	in	in	B-PP	IN	O	25	NMOD	O
O	O	458	465	natural	natural	B-NP	JJ	B-cell_type	43	NMOD	B-cell_type
O	O	466	472	killer	killer	I-NP	NN	I-cell_type	43	NMOD	I-cell_type
O	O	473	478	cells	cell	I-NP	NNS	I-cell_type	45	NMOD	I-cell_type
O	O	479	482	and	and	O	CC	O	45	NMOD	O
O	O	483	494	macrophages	macrophage	B-NP	NNS	B-cell_type	40	PMOD	B-cell_type
O	O	494	495	;	;	O	:	O	48	P	O
O	O	496	499	and	and	O	CC	O	48	NMOD	O
O	O	500	504	part	part	B-NP	NN	O	2	PRD	O
O	O	505	507	of	of	B-PP	IN	O	48	NMOD	O
O	O	508	511	the	the	B-NP	DT	O	54	NMOD	O
O	O	512	513	T	T	I-NP	NN	B-protein	54	NMOD	B-protein
O	O	514	518	cell	cell	I-NP	NN	I-protein	54	NMOD	I-protein
O	O	519	526	antigen	antigen	I-NP	NN	I-protein	54	NMOD	I-protein
O	O	527	535	receptor	receptor	I-NP	NN	I-protein	49	PMOD	I-protein
O	O	536	538	in	in	B-PP	IN	O	48	NMOD	O
O	O	539	546	subsets	subset	B-NP	NNS	O	55	PMOD	O
O	O	547	549	of	of	B-PP	IN	O	56	NMOD	O
O	O	550	551	T	T	B-NP	NN	B-cell_type	59	NMOD	B-cell_type
O	O	552	557	cells	cell	I-NP	NNS	I-cell_type	57	PMOD	I-cell_type
O	O	557	558	.	.	O	.	O	2	P	O

O	O	559	563	Here	Here	B-ADVP	RB	O	3	VMOD	O
O	O	564	566	we	we	B-NP	PRP	O	3	SUB	O
O	O	567	571	have	have	B-VP	VBP	O	0	ROOT	O
O	O	572	584	investigated	investigate	I-VP	VBN	O	3	VC	O
O	O	585	588	the	the	B-NP	DT	O	7	NMOD	O
O	O	589	604	transcriptional	transcriptional	I-NP	JJ	O	7	NMOD	O
O	O	605	615	regulation	regulation	I-NP	NN	O	4	OBJ	O
O	O	616	618	of	of	B-PP	IN	O	7	NMOD	O
O	O	619	622	the	the	B-NP	DT	O	12	NMOD	O
T8	B-Entity	623	628	gamma	gamma	I-NP	NN	B-DNA	12	NMOD	B-DNA
T8	I-Entity	629	634	chain	chain	I-NP	NN	I-DNA	12	NMOD	I-DNA
T8	I-Entity	635	639	gene	gene	I-NP	NN	I-DNA	8	PMOD	I-DNA
O	O	640	642	by	by	B-PP	IN	O	4	VMOD	O
O	O	643	652	analyzing	analyze	B-VP	VBG	O	13	PMOD	O
O	O	653	656	the	the	B-NP	DT	O	21	NMOD	O
T9	B-Entity	657	658	2	2	I-NP	CD	B-DNA	21	NMOD	B-DNA
T9	I-Entity	658	659	.	.	I-NP	SYM	I-DNA	21	NMOD	I-DNA
T9	I-Entity	659	660	5	5	I-NP	CD	I-DNA	21	NMOD	I-DNA
T9	I-Entity	660	661	-	-	I-NP	HYPH	I-DNA	21	NMOD	I-DNA
T9	I-Entity	661	669	kilobase	kilobase	I-NP	NN	I-DNA	21	NMOD	I-DNA
T9	I-Entity	670	678	sequence	sequence	I-NP	NN	I-DNA	14	OBJ	I-DNA
O	O	679	687	upstream	upstream	B-ADJP	JJ	O	21	NMOD	O
O	O	688	690	of	of	B-PP	IN	O	22	AMOD	O
O	O	691	694	the	the	B-NP	DT	O	27	NMOD	O
T10	B-Entity	695	708	transcription	transcription	I-NP	NN	B-DNA	27	NMOD	B-DNA
T10	I-Entity	709	714	start	start	I-NP	NN	I-DNA	27	NMOD	I-DNA
T10	I-Entity	715	719	site	site	I-NP	NN	I-DNA	23	PMOD	I-DNA
O	O	719	720	.	.	O	.	O	3	P	O

O	O	721	725	This	This	B-NP	DT	O	2	NMOD	O
O	O	726	734	sequence	sequence	I-NP	NN	O	3	SUB	O
O	O	735	743	contains	contain	B-VP	VBZ	O	0	ROOT	O
O	O	744	745	a	a	B-NP	DT	O	5	NMOD	O
T11	B-Entity	746	754	promoter	promoter	I-NP	NN	B-DNA	3	OBJ	B-DNA
O	O	755	763	specific	specific	B-ADJP	JJ	O	5	NMOD	O
O	O	764	766	to	to	B-PP	TO	O	6	AMOD	O
O	O	767	772	cells	cell	B-NP	NNS	O	7	PMOD	O
O	O	773	775	of	of	B-PP	IN	O	8	NMOD	O
O	O	776	789	hematopoietic	hematopoietic	B-NP	JJ	B-cell_type	11	NMOD	B-cell_type
O	O	790	797	lineage	lineage	I-NP	NN	I-cell_type	9	PMOD	I-cell_type
O	O	797	798	.	.	O	.	O	3	P	O

O	O	799	806	However	However	B-ADVP	RB	O	9	VMOD	O
O	O	806	807	,	,	O	,	O	9	P	O
O	O	808	811	the	the	B-NP	DT	O	5	NMOD	O
O	O	812	818	tissue	tissue	I-NP	NN	O	5	NMOD	O
O	O	819	830	specificity	specificity	I-NP	NN	O	9	SUB	O
O	O	831	833	of	of	B-PP	IN	O	5	NMOD	O
O	O	834	838	this	this	B-NP	DT	O	8	NMOD	O
T12	B-Entity	839	847	promoter	promoter	I-NP	NN	B-DNA	6	PMOD	B-DNA
O	O	848	850	is	be	B-VP	VBZ	O	0	ROOT	O
O	O	851	855	only	only	B-ADJP	RB	O	11	AMOD	O
O	O	856	863	partial	partial	I-ADJP	JJ	O	9	PRD	O
O	O	864	871	because	because	B-SBAR	IN	O	9	VMOD	O
O	O	872	874	it	it	B-NP	PRP	O	14	SUB	O
O	O	875	877	is	be	B-VP	VBZ	O	12	SBAR	O
O	O	878	884	active	active	B-ADJP	JJ	O	14	PRD	O
O	O	885	887	in	in	B-PP	IN	O	15	AMOD	O
O	O	888	891	all	all	B-NP	DT	O	16	PMOD	O
O	O	892	894	of	of	B-PP	IN	O	17	NMOD	O
O	O	895	898	the	the	B-NP	DT	O	21	NMOD	O
O	O	899	912	hematopoietic	hematopoietic	I-NP	JJ	B-cell_type	21	NMOD	B-cell_type
O	O	913	918	cells	cell	I-NP	NNS	I-cell_type	18	PMOD	I-cell_type
O	O	919	925	tested	test	B-VP	VBN	O	21	NMOD	O
O	O	926	930	here	here	B-ADVP	RB	O	22	VMOD	O
O	O	930	931	,	,	O	,	O	16	P	O
O	O	932	942	regardless	regardless	B-ADVP	RB	O	16	PMOD	O
O	O	943	945	of	of	B-PP	IN	O	25	AMOD	O
O	O	946	953	whether	whether	B-SBAR	IN	O	26	PMOD	O
O	O	954	958	they	they	B-NP	PRP	O	30	SUB	O
O	O	959	973	constitutively	constitutively	B-VP	RB	O	30	VMOD	O
O	O	974	981	express	express	I-VP	VBP	O	27	SBAR	O
T4	B-Protein	982	984	Fc	Fc	B-NP	NN	B-protein	33	NMOD	B-protein
T4	I-Protein	985	992	epsilon	epsilon	I-NP	NN	I-protein	33	NMOD	I-protein
T4	I-Protein	993	995	RI	RI	I-NP	NN	I-protein	30	OBJ	I-protein
T4	I-Protein	995	996	-	-	O	HYPH	O	37	P	O
T4	I-Protein	997	1002	gamma	gamma	B-NP	SYM	B-RNA	37	NMOD	B-RNA
T4	I-Protein	1003	1008	chain	chain	I-NP	NN	I-RNA	37	NMOD	I-RNA
O	O	1009	1020	transcripts	transcript	I-NP	NNS	I-RNA	30	OBJ	I-RNA
O	O	1020	1021	.	.	O	.	O	9	P	O

O	O	1022	1024	We	We	B-NP	PRP	O	2	SUB	O
O	O	1025	1029	have	have	B-VP	VBP	O	0	ROOT	O
O	O	1030	1040	identified	identify	I-VP	VBN	O	2	VC	O
O	O	1041	1044	two	two	B-NP	CD	O	6	NMOD	O
O	O	1045	1053	adjacent	adjacent	I-NP	JJ	O	6	NMOD	O
T13	B-Entity	1054	1057	cis	cis	I-NP	NN	O	10	NMOD	O
T13	I-Entity	1057	1058	-	-	B-PP	HYPH	O	10	P	O
T13	I-Entity	1058	1064	acting	act	B-NP	VBG	O	10	NMOD	O
T13	I-Entity	1065	1075	regulatory	regulatory	I-NP	JJ	B-DNA	10	NMOD	B-DNA
T13	I-Entity	1076	1084	elements	element	I-NP	NNS	I-DNA	3	OBJ	I-DNA
O	O	1084	1085	,	,	O	,	O	10	P	O
O	O	1086	1090	both	both	B-NP	DT	O	13	NMOD	O
O	O	1091	1093	of	of	B-PP	IN	O	10	NMOD	O
O	O	1094	1099	which	which	B-NP	WDT	O	13	PMOD	O
O	O	1100	1103	are	be	B-VP	VBP	O	13	SBAR	O
O	O	1104	1108	part	part	B-NP	NN	O	15	PRD	O
O	O	1109	1111	of	of	B-PP	IN	O	16	NMOD	O
O	O	1112	1114	an	an	B-NP	DT	O	20	NMOD	O
T14	B-Entity	1115	1118	Alu	Alu	I-NP	NN	B-DNA	20	NMOD	B-DNA
T14	I-Entity	1119	1125	repeat	repeat	I-NP	NN	I-DNA	17	PMOD	I-DNA
O	O	1125	1126	.	.	O	.	O	2	P	O

T15	B-Entity	1127	1130	The	The	B-NP	DT	O	2	NMOD	O
T15	I-Entity	1131	1136	first	first	I-NP	JJ	O	10	SUB	O
T15	I-Entity	1137	1138	(	(	O	(	O	9	DEP	O
T15	I-Entity	1138	1139	-	-	O	SYM	O	9	DEP	O
T15	I-Entity	1139	1142	445	445	B-NP	CD	O	8	NMOD	O
T15	I-Entity	1142	1143	/	/	I-NP	SYM	O	7	AMOD	O
T15	I-Entity	1143	1144	-	-	I-NP	SYM	O	8	NMOD	O
T15	I-Entity	1144	1147	366	366	I-NP	CD	O	4	PRD	O
T15	I-Entity	1147	1148	)	)	O	)	O	2	NMOD	O
O	O	1149	1151	is	be	B-VP	VBZ	O	0	ROOT	O
O	O	1152	1153	a	a	B-NP	DT	O	13	NMOD	O
O	O	1154	1162	positive	positive	I-NP	JJ	B-DNA	13	NMOD	B-DNA
O	O	1163	1170	element	element	I-NP	NN	I-DNA	10	PRD	I-DNA
O	O	1171	1177	active	active	B-ADJP	JJ	O	13	NMOD	O
O	O	1178	1180	in	in	B-PP	IN	O	14	AMOD	O
O	O	1181	1185	both	both	O	CC	O	20	NMOD	O
O	O	1186	1195	basophils	basophil	B-NP	NNS	B-cell_type	20	NMOD	B-cell_type
O	O	1196	1199	and	and	O	CC	O	20	NMOD	O
O	O	1200	1201	T	T	B-NP	NN	B-cell_type	20	NMOD	B-cell_type
O	O	1202	1207	cells	cell	B-NP	NNS	I-cell_type	15	PMOD	I-cell_type
O	O	1207	1208	.	.	O	.	O	10	P	O

T16	B-Entity	1209	1212	The	The	B-NP	DT	O	2	NMOD	O
T16	I-Entity	1213	1219	second	second	I-NP	JJ	O	10	SUB	O
T16	I-Entity	1220	1221	(	(	O	(	O	9	DEP	O
T16	I-Entity	1221	1222	-	-	O	SYM	O	9	DEP	O
T16	I-Entity	1222	1225	365	365	B-NP	CD	O	8	NMOD	O
T16	I-Entity	1225	1226	/	/	I-NP	SYM	O	7	AMOD	O
T16	I-Entity	1226	1227	-	-	I-NP	SYM	O	8	NMOD	O
T16	I-Entity	1227	1230	264	264	I-NP	CD	O	4	PRD	O
T16	I-Entity	1230	1231	)	)	O	)	O	2	NMOD	O
O	O	1232	1237	binds	bind	B-VP	VBZ	O	0	ROOT	O
O	O	1238	1240	to	to	B-PP	TO	O	10	VMOD	O
O	O	1241	1248	nuclear	nuclear	B-NP	JJ	B-protein	13	NMOD	B-protein
O	O	1249	1256	factors	factor	I-NP	NNS	I-protein	11	PMOD	I-protein
O	O	1256	1257	,	,	O	,	O	13	P	O
O	O	1258	1263	which	which	B-NP	WDT	O	13	NMOD	O
O	O	1264	1270	appear	appear	B-VP	VBP	O	15	SBAR	O
O	O	1271	1273	to	to	I-VP	TO	O	18	VMOD	O
O	O	1274	1276	be	be	I-VP	VB	O	16	VMOD	O
O	O	1277	1286	different	different	B-ADJP	JJ	O	18	PRD	O
O	O	1287	1289	in	in	B-PP	IN	O	18	VMOD	O
O	O	1290	1299	basophils	basophil	B-NP	NNS	B-cell_type	24	NMOD	B-cell_type
O	O	1300	1303	and	and	O	CC	O	24	NMOD	O
O	O	1304	1305	T	T	B-NP	NN	B-cell_type	24	NMOD	B-cell_type
O	O	1306	1311	cells	cell	I-NP	NNS	I-cell_type	20	PMOD	I-cell_type
O	O	1311	1312	,	,	O	,	O	10	P	O
O	O	1313	1316	and	and	O	CC	O	10	VMOD	O
O	O	1317	1321	acts	act	B-VP	VBZ	O	10	VMOD	O
O	O	1322	1324	as	as	B-PP	IN	O	27	VMOD	O
O	O	1325	1326	a	a	B-NP	DT	O	31	NMOD	O
O	O	1327	1335	negative	negative	I-NP	JJ	B-DNA	31	NMOD	B-DNA
O	O	1336	1343	element	element	I-NP	NN	I-DNA	28	PMOD	I-DNA
O	O	1344	1346	in	in	B-PP	IN	O	27	VMOD	O
O	O	1347	1356	basophils	basophil	B-NP	NNS	B-cell_type	32	PMOD	B-cell_type
O	O	1357	1360	and	and	B-PP	CC	O	27	VMOD	O
O	O	1361	1363	as	as	B-PP	IN	O	27	VMOD	O
O	O	1364	1365	a	a	B-NP	DT	O	38	NMOD	O
O	O	1366	1374	positive	positive	I-NP	JJ	O	38	NMOD	O
O	O	1375	1378	one	one	I-NP	NN	O	35	PMOD	O
O	O	1379	1381	in	in	B-PP	IN	O	38	NMOD	O
O	O	1382	1383	T	T	B-NP	NN	B-cell_type	41	NMOD	B-cell_type
O	O	1384	1389	cells	cell	I-NP	NNS	I-cell_type	39	PMOD	I-cell_type
O	O	1389	1390	.	.	O	.	O	10	P	O

O	O	1391	1395	Thus	Thus	B-ADVP	RB	O	15	VMOD	O
O	O	1395	1396	,	,	O	,	O	15	P	O
O	O	1397	1401	this	this	B-NP	DT	O	5	NMOD	O
T17	B-Entity	1402	1405	Alu	Alu	I-NP	NN	B-DNA	5	NMOD	B-DNA
T17	I-Entity	1406	1412	repeat	repeat	I-NP	NN	I-DNA	15	SUB	I-DNA
O	O	1413	1414	(	(	O	(	O	14	DEP	O
O	O	1414	1416	90	90	B-NP	CD	O	8	NMOD	O
O	O	1416	1417	%	%	I-NP	NN	O	9	AMOD	O
O	O	1418	1427	identical	identical	B-ADJP	JJ	O	14	DEP	O
O	O	1428	1430	to	to	B-PP	TO	O	9	AMOD	O
T18	B-Entity	1431	1434	Alu	Alu	B-NP	NN	B-DNA	13	NMOD	B-DNA
T18	I-Entity	1435	1444	consensus	consensus	I-NP	NN	I-DNA	13	NMOD	I-DNA
T18	I-Entity	1445	1454	sequences	sequence	I-NP	NNS	I-DNA	10	PMOD	I-DNA
O	O	1454	1455	)	)	O	)	O	5	NMOD	O
O	O	1456	1459	has	have	B-VP	VBZ	O	0	ROOT	O
O	O	1460	1467	evolved	evolve	I-VP	VBN	O	15	VC	O
O	O	1468	1470	to	to	B-VP	TO	O	18	VMOD	O
O	O	1471	1477	become	become	I-VP	VB	O	16	VMOD	O
O	O	1478	1482	both	both	O	CC	O	24	NMOD	O
O	O	1483	1484	a	a	B-NP	DT	O	24	NMOD	O
O	O	1485	1493	positive	positive	I-NP	JJ	O	23	AMOD	O
O	O	1494	1497	and	and	I-NP	CC	O	23	AMOD	O
O	O	1498	1506	negative	negative	I-NP	JJ	O	24	NMOD	O
T19	B-Entity	1507	1516	regulator	regulator	I-NP	NN	O	18	PRD	O
O	O	1516	1517	.	.	O	.	O	15	P	O
